Search Results
Search for other papers by Maya Dadiani in
Google Scholar
PubMed
Search for other papers by Dalia Seger in
Google Scholar
PubMed
Search for other papers by Tamar Kreizman in
Google Scholar
PubMed
Search for other papers by Daria Badikhi in
Google Scholar
PubMed
Search for other papers by Raanan Margalit in
Google Scholar
PubMed
Search for other papers by Raya Eilam in
Google Scholar
PubMed
Search for other papers by Hadassa Degani in
Google Scholar
PubMed
necessary to elucidate the cascade of molecular events downstream of the estrogen receptors α and β (ERα and ERβ). Both receptors mediate the activity of estrogen in a variety of normal and malignant cells and tissues, with the levels of the two receptors
Search for other papers by Silvia Darb-Esfahani in
Google Scholar
PubMed
Search for other papers by Ralph M Wirtz in
Google Scholar
PubMed
Search for other papers by Bruno V Sinn in
Google Scholar
PubMed
Search for other papers by Jan Budczies in
Google Scholar
PubMed
Search for other papers by Aurelia Noske in
Google Scholar
PubMed
Search for other papers by Wilko Weichert in
Google Scholar
PubMed
Search for other papers by Areeg Faggad in
Google Scholar
PubMed
Search for other papers by Susanne Scharff in
Google Scholar
PubMed
Search for other papers by Jalid Sehouli in
Google Scholar
PubMed
Search for other papers by Guelten Oskay-Özcelik in
Google Scholar
PubMed
Search for other papers by Claudio Zamagni in
Google Scholar
PubMed
Search for other papers by Pierandrea De Iaco in
Google Scholar
PubMed
Search for other papers by Andrea Martoni in
Google Scholar
PubMed
Search for other papers by Manfred Dietel in
Google Scholar
PubMed
Search for other papers by Carsten Denkert in
Google Scholar
PubMed
Using immunohistochemistry, we evaluated ERα protein expression in ovarian carcinoma. We found a highly significant correlation between ER-protein expression and the results of the quantitative PCR ( P <0.0001; Kruskal–Wallis test); however, there was a
Search for other papers by Maxy De los Santos in
Google Scholar
PubMed
Search for other papers by Olaia Martínez-Iglesias in
Google Scholar
PubMed
Search for other papers by Ana Aranda in
Google Scholar
PubMed
Introduction Estrogen plays a key role in normal breast development, as well as in growth and progression of breast cancer. The biological actions of estrogen are mediated by binding to nuclear estrogen receptors (ERα and ERβ). In breast cancer
Search for other papers by Cameron M Armstrong in
Google Scholar
PubMed
Search for other papers by Autumn R Billimek in
Google Scholar
PubMed
Search for other papers by Kimberly F Allred in
Google Scholar
PubMed
Search for other papers by Joseph M Sturino in
Google Scholar
PubMed
Search for other papers by Brad R Weeks in
Google Scholar
PubMed
Search for other papers by Clinton D Allred in
Google Scholar
PubMed
plate reader at 415 nm, and the final E 2 concentrations were determined by comparison with standards using the formula supplied in the kit. Immunohistochemistry for ERβ, ERα, and BrdU From the PFA-fixed tissues, 4 μm sections were taken. The sections
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Steven M Hill in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Victoria P Belancio in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Robert T Dauchy in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Shulin Xiang in
Google Scholar
PubMed
Search for other papers by Samantha Brimer in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Lulu Mao in
Google Scholar
PubMed
Search for other papers by Adam Hauch in
Google Scholar
PubMed
Search for other papers by Peter W Lundberg in
Google Scholar
PubMed
Search for other papers by Whitney Summers in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Lin Yuan in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by Tripp Frasch in
Google Scholar
PubMed
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Department of Structural and Cellular Biology, Department of Surgery, Tulane Cancer Center and Louisiana Cancer Research Consortium, Circadian Cancer Biology Group, Tulane Center for Circadian Biology, Tulane University School of Medicine, 1430 Tulane Avenue, SL-49, New Orleans, Louisiana 70112, USA
Search for other papers by David E Blask in
Google Scholar
PubMed
actions in ERα-positive MCF-7 human breast cancer cells. Employing MCF-7 human breast cancer cells, we reported that melatonin-activated MT 1 receptors couple to Gα i2 , Gα i3 , Gα q , and Gα 11 proteins ( Lai et al . 2008 ). Overexpression of the MT 1
Search for other papers by Lesley-Ann Martin in
Google Scholar
PubMed
Search for other papers by Ian Farmer in
Google Scholar
PubMed
Search for other papers by Stephen R D Johnston in
Google Scholar
PubMed
Search for other papers by Simak Ali in
Google Scholar
PubMed
Search for other papers by Mitch Dowsett in
Google Scholar
PubMed
patients who have relapsed on aromatase inhibitors with high doses of E2 may exploit this phenomenon providing clinical benefit. Further analysis of our LTED cell line showed a marked elevation in ERα which was phosphorylated on serine 118 (Ser 118
Search for other papers by Evangelia-Ourania Fourkala in
Google Scholar
PubMed
Department of Gynecological Oncology, Department of Mathematics, Department of Clinical Biochemistry, Department of Molecular Bioenergetics, Academic Health Science Centre, Institute for Women's Health, Gynecological Cancer Research Centre, University College London, 149 Tottenham Road, London W1T 7DN, UK
Search for other papers by Alexey Zaikin in
Google Scholar
PubMed
Search for other papers by Matthew Burnell in
Google Scholar
PubMed
Search for other papers by Aleksandra Gentry-Maharaj in
Google Scholar
PubMed
Search for other papers by Jeremy Ford in
Google Scholar
PubMed
Search for other papers by Richard Gunu in
Google Scholar
PubMed
Search for other papers by Christina Soromani in
Google Scholar
PubMed
Search for other papers by Guido Hasenbrink in
Google Scholar
PubMed
Search for other papers by Ian Jacobs in
Google Scholar
PubMed
Search for other papers by Anne Dawnay in
Google Scholar
PubMed
Search for other papers by Martin Widschwendter in
Google Scholar
PubMed
Search for other papers by Hella Lichtenberg-Fraté in
Google Scholar
PubMed
Search for other papers by Usha Menon in
Google Scholar
PubMed
attractive alternative for breast cancer risk assessment. We found that estrogen receptor α (ERα) and ERβ serum bioactivity (SB) are independently associated with breast cancer using samples collected at diagnosis ( Widschwendter et al . 2009 ). To better
Search for other papers by T M Sadler in
Google Scholar
PubMed
Search for other papers by M Gavriil in
Google Scholar
PubMed
Search for other papers by T Annable in
Google Scholar
PubMed
Search for other papers by P Frost in
Google Scholar
PubMed
Search for other papers by L M Greenberger in
Google Scholar
PubMed
Search for other papers by Y Zhang in
Google Scholar
PubMed
breast cancer and stimulates tumor growth through estrogen receptor-α (ERα), which is a member of a large family of ligand-inducible transcription factors ( McKenna & O’Malley 2001 , Reid et al. 2002 , Germain et al. 2003 ). Upon binding to its
Search for other papers by Tobias Zellweger in
Google Scholar
PubMed
Search for other papers by Susanne Stürm in
Google Scholar
PubMed
Search for other papers by Silvia Rey in
Google Scholar
PubMed
Search for other papers by Inti Zlobec in
Google Scholar
PubMed
Search for other papers by Joel R Gsponer in
Google Scholar
PubMed
Department of Urology, Institute for Pathology, Institute of Pathology, Department of Urology, St Claraspital, Basel, Switzerland
Search for other papers by Cyrill A Rentsch in
Google Scholar
PubMed
Search for other papers by Luigi M Terracciano in
Google Scholar
PubMed
Search for other papers by Alexander Bachmann in
Google Scholar
PubMed
Search for other papers by Lukas Bubendorf in
Google Scholar
PubMed
Search for other papers by Christian Ruiz in
Google Scholar
PubMed
, evidence has accumulated that estrogens and their corresponding receptors (ERα and ERβ) can significantly influence PC growth and progression. Both receptors are expressed in the adult prostate, but whereas ERα expression appears to be restricted to the
Search for other papers by E M Rosen in
Google Scholar
PubMed
Search for other papers by S Fan in
Google Scholar
PubMed
Search for other papers by C Isaacs in
Google Scholar
PubMed
activator BRG1, the cofactor of BRCA1 (COBRA1)), and other transcriptional regulatory proteins ( Rosen et al. 2003 ). BRCA1 regulation of steroid hormone receptor action Estrogen receptor (ER-α) A